Gabr, M.M.; AbdelHamid, S.G.; Ezz El Arab, L.R.; Swellam, M.; Hamdy, N.M.
MGMT, NUPR1, NDRG2, and GLI1 Gene Promoter Methylation in Glioblastoma Tissues and Association with Clinical Characteristics and Therapeutic Outcomes. Int. J. Mol. Sci. 2026, 27, 763.
https://doi.org/10.3390/ijms27020763
AMA Style
Gabr MM, AbdelHamid SG, Ezz El Arab LR, Swellam M, Hamdy NM.
MGMT, NUPR1, NDRG2, and GLI1 Gene Promoter Methylation in Glioblastoma Tissues and Association with Clinical Characteristics and Therapeutic Outcomes. International Journal of Molecular Sciences. 2026; 27(2):763.
https://doi.org/10.3390/ijms27020763
Chicago/Turabian Style
Gabr, Mariam M., Sherihan G. AbdelHamid, Lobna R. Ezz El Arab, Menha Swellam, and Nadia M. Hamdy.
2026. "MGMT, NUPR1, NDRG2, and GLI1 Gene Promoter Methylation in Glioblastoma Tissues and Association with Clinical Characteristics and Therapeutic Outcomes" International Journal of Molecular Sciences 27, no. 2: 763.
https://doi.org/10.3390/ijms27020763
APA Style
Gabr, M. M., AbdelHamid, S. G., Ezz El Arab, L. R., Swellam, M., & Hamdy, N. M.
(2026). MGMT, NUPR1, NDRG2, and GLI1 Gene Promoter Methylation in Glioblastoma Tissues and Association with Clinical Characteristics and Therapeutic Outcomes. International Journal of Molecular Sciences, 27(2), 763.
https://doi.org/10.3390/ijms27020763